Improving Weight Loss Outcomes for Binge Eating Disorder

改善暴食症的减肥效果

基本信息

  • 批准号:
    9755423
  • 负责人:
  • 金额:
    $ 47.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Binge eating disorder (BED) is the most prevalent eating disorder and is associated with substantial psychiatric and medical comorbidity. Although obesity is not part of the diagnostic criteria for BED, more than 65% of individuals with BED are obese, and more than a quarter of patients seeking treatment for obesity present with BED. To date, although there exist several effective treatments for reducing binge eating, facilitating clinically significant weight loss in patients with BED remains a challenge. We believe the failure of existing treatment approaches is related to 1) a lack of emphasize on altering the calorie balance (through both diet and physical activity) without encouraging strict dietary restraint that could promote an eventual re- occurrence of binge eating pathology, 2) limited strategies designed to promote long-term adherence to dietary and physical activity goals, and 3) the failure of both standard behavioral weight loss treatments (SBT) and cognitive behavioral therapy (CBT) to address key maintenance factors for BED (e.g. elevated food reward sensitivity, overvaluation of weight and shape, negative affect and distress intolerance). Acceptance-based behavioral treatment (ABBT) can provide individuals with the psychological tools necessary to improve negative affect, distress intolerance, and overvaluation of weight and shape and support long-term adherence to the dietary and physical activity recommendations designed to produce weight loss despite elevated food reward sensitivity. Our existing pilot data support the ability of ABBTs to produce superior weight loss outcomes both for obese patients at large and for obese patients with vulnerabilities similar to those observed in BED. ABBTs have also been shown to effectively reduce binge eating episodes in BED. Our pilot data suggests that ABBT could produce superior weight loss outcomes for patients with BED compared to SBT. The primary goal of the proposed project is to evaluate the efficacy of ABBT in relation to SBT for facilitating weight loss and weight loss maintenance in patients with BED. A secondary goal is to test hypothesized mechanisms of action of the two treatments, both during active intervention and during the post-treatment weight loss maintenance phase. Lastly, we aim to evaluate moderation hypotheses stating that the superiority of ABBT will be especially pronounced for those with higher food reward sensitivity, overvaluation of weight and shape, negative affect, and distress intolerance. Our aims work towards longer-range goals of identifying more effective methods for improving weight loss outcomes, using evidence to maximize the effective components of interventions, and matching patients to treatment type. Accordingly, we will randomly assign 130 overweight and obese patients with BED to 25 sessions of ABBT or SBT. All participants will be followed until one year post-treatment. Lab-based behavioral assessments, clinician guided interventions, and self- report measures will be used to provide a multi-method assessment of hypothesized moderating and mediating pathways, and how these associations are affected by treatment.
项目摘要/摘要 暴饮暴食障碍(Bed)是最普遍的饮食障碍,与大量 精神疾病和医学上的共病。尽管肥胖不是床上的诊断标准的一部分,但超过 65%的卧床者患有肥胖症,超过四分之一的肥胖症患者寻求治疗 带床的礼物。到目前为止,虽然有几种有效的治疗方法可以减少暴饮暴食, 在有床的患者中促进临床显著的体重减轻仍然是一个挑战。我们相信失败的原因 现有的治疗方法与1)缺乏对改变卡路里平衡的重视(通过两者 饮食和体力活动),而不鼓励严格的饮食限制,这可能会促进最终的 暴食病理的发生,2)旨在促进长期坚持饮食的有限策略 和体力活动目标,以及3)标准行为减肥治疗(SBT)和 认知行为疗法(CBT),以解决床上的关键维持因素(例如,提高食物奖励 敏感性、对重量和形状的高估、负面影响和对痛苦的不容忍)。以接受为基础 行为治疗(ABBT)可以为个人提供必要的心理工具,以改善 消极的情绪,痛苦的不耐性,以及对体重和体型的高估,并支持长期坚持 符合饮食和体力活动的建议,即使食物含量升高,也能减肥 奖励敏感度。我们现有的试验数据支持ABBTS产生卓越减肥效果的能力 一般肥胖患者和易损性与观察结果相似的肥胖患者的结果 在床上。ABBT也被证明可以有效地减少床上暴饮暴食的次数。我们的试点数据 提示与SBT相比,ABBT对卧床患者的减肥效果更好。 拟议项目的主要目标是评估ABBT相对于SBT的功效,以促进 减肥和减肥维持性患者卧床。第二个目标是测试假设 两种治疗方法在积极干预和治疗后的作用机制 减肥维持期。最后,我们的目标是评估适度假设,表明 对于那些食物奖励敏感度较高、体重过高的人,ABBT的影响尤其明显 以及形体、消极情绪和对痛苦的不容忍。我们的目标是实现更长远的目标,即确定 更有效的方法来改善减肥效果,使用证据来最大限度地提高有效性 干预措施的组成部分,以及将患者与治疗类型相匹配。因此,我们将随机分配 130名超重和肥胖患者与床上进行25次ABBT或SBT。所有参与者都将被跟踪 直到治疗后一年。基于实验室的行为评估、临床医生指导的干预和自我 报告措施将被用来提供对假设的调解和调解的多方法评估 途径,以及治疗如何影响这些联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADRIENNE SARAH JUARASCIO其他文献

ADRIENNE SARAH JUARASCIO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADRIENNE SARAH JUARASCIO', 18)}}的其他基金

Optimizing digital health technologies to improve therapeutic skill use and acquisition
优化数字健康技术以改善治疗技能的使用和获取
  • 批准号:
    10597202
  • 财政年份:
    2022
  • 资助金额:
    $ 47.07万
  • 项目类别:
Optimizing digital health technologies to improve therapeutic skill use and acquisition
优化数字健康技术以改善治疗技能的使用和获取
  • 批准号:
    10429134
  • 财政年份:
    2022
  • 资助金额:
    $ 47.07万
  • 项目类别:
Reward Re-Training: A new treatment to address reward imbalance during the COVID-19 pandemic
奖励再培训:解决 COVID-19 大流行期间奖励失衡的新疗法
  • 批准号:
    10218350
  • 财政年份:
    2020
  • 资助金额:
    $ 47.07万
  • 项目类别:
Optimizing Mindfulness and Acceptance-Based Treatments for Bulimia Nervosa and Binge Eating Disorder using a Factorial Design
使用析因设计优化针对神经性贪食症和暴食症的正念和基于接受的治疗
  • 批准号:
    10612758
  • 财政年份:
    2020
  • 资助金额:
    $ 47.07万
  • 项目类别:
Optimizing Mindfulness and Acceptance-Based Treatments for Bulimia Nervosa and Binge Eating Disorder using a Factorial Design
使用析因设计优化针对神经性贪食症和暴食症的正念和基于接受的治疗
  • 批准号:
    10356884
  • 财政年份:
    2020
  • 资助金额:
    $ 47.07万
  • 项目类别:
Using Continuous Glucose Monitoring to Detect and Intervene on Maintenance Factors for Transdiagnostic Binge Eating Pathology
使用连续血糖监测来检测和干预跨诊断性暴食病理学的维持因素
  • 批准号:
    9908791
  • 财政年份:
    2019
  • 资助金额:
    $ 47.07万
  • 项目类别:
Using Continuous Glucose Monitoring to Detect and Intervene on Maintenance Factors for Transdiagnostic Binge Eating Pathology
使用连续血糖监测来检测和干预跨诊断性暴食病理学的维持因素
  • 批准号:
    10023279
  • 财政年份:
    2019
  • 资助金额:
    $ 47.07万
  • 项目类别:
Improving Weight Loss Outcomes for Binge Eating Disorder
改善暴食症的减肥效果
  • 批准号:
    10207616
  • 财政年份:
    2018
  • 资助金额:
    $ 47.07万
  • 项目类别:
Improving Weight Loss Outcomes for Binge Eating Disorder
改善暴食症的减肥效果
  • 批准号:
    10457919
  • 财政年份:
    2018
  • 资助金额:
    $ 47.07万
  • 项目类别:
Addressing Weight History to Improve Behavioral Treatments for Bulimia Nervosa
解决体重史以改善神经性贪食症的行为治疗
  • 批准号:
    8891738
  • 财政年份:
    2015
  • 资助金额:
    $ 47.07万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 47.07万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了